Pfizer is preparing to launch its hemophilia B gene therapy Beqvez (fidanacogene elaparvovec-dzkt) after securing a U.S. approval for the treatment last month.
Beqvez is the second gene therapy to be approved for adults with moderate to severe hemophilia B in the U.S., following the clearance of Hemgenix in 2022.
With the U.S. approval of BEQVEZ, physicians and patients now have another choice in the treatment of hemophilia B, Sonal Bhatia, MD, senior vice president and head of U.S. specialty care medical affairs at Pfizer, said in a written Q&A with Hemophilia News Today.
Beqvez is also cleared in Canada and is under review in the European Union.
Bhatia said gene therapies, which directly address the diseases underlying cause, offer transformative potential for long-term bleed control in eligible patients, who are often susceptible to breakthrough bleeds despite being on standard of care preventive therapies.
There is a clear interest and anticipation from the physician and patient community for gene therapy and its potential use alongside conventional treatments, Bhatia said.
Pfizer is focusing on Beqvezs rollout. The therapy is expected to become available by prescription to eligible patients this quarter, Bhatia said.
The company is proactively working with treatment centers, payers, and the hemophilia community to help ensure the healthcare system is appropriately prepared to deliver Beqvez to the patients who can benefit from it, she said.
That includes offering personalized patient support services through Pfizers GeneTogether program. Through the program, patients can access educational materials about what happens before, during, and after receiving gene therapy, and can find help understanding insurance coverage and financial options.
Gene therapies are among the most expensive treatments in the world. Beqvez has a list price of $3.5 million, the same as Hemgenix.
To help ensure that insurance companies are willing to cover the cost, Pfizer is offering a warranty program based on the durability of a patients response, Bhatia said. The program provides financial protection by insuring against the risk of efficacy failure, with the aim of making it easier for patients to access treatment, she said.
Pfizer also offers a co-pay assistance program to help manage out-of-pocket costs for patients who are commercially insured.
Factor replacement therapy has long been the standard prophylactic treatment for hemophilia B. It involves regularly administering infusions into the bloodstream of a working version of factor IX (FIX), the blood clotting protein patients thats faulty or missing due to mutations in the F9 gene that encodes its production.
But despite these treatments, many people living with moderate to severe hemophilia B are at risk of spontaneous bleeding episodes, which can result in painful joint damage and mobility issues, Bhatia said.
This can significantly affect a persons daily life. Bhatia pointed to studies showing that nearly 40% of severe hemophilia patients who are employed experience disease-related restrictions in job performance, and that at least 13% have faced unemployment because of it.
With Beqvez, the hope is to allow people living with hemophilia more time for the things they love and support their ability to engage in the workforce, school, and society, Bhatia said.
The gene therapy, intended as a one-time treatment, provides patients liver cells with a healthy copy of F9. The therapy provides the body with the tools to continuously produce its own FIX protein in the long term, offering lasting bleed prevention.
The potential benefits of Beqvez were demonstrated in the open-label Phase 3 BENEGENE-2 clinical trial (NCT03861273), which tested the effects of the gene therapy in men, ages 18-65, with moderate to severe hemophilia B.
Bleeds were eliminated in 60% of patients after they received Beqvez for up to three years, while only 29% of patients experienced complete bleed control while on standard prophylaxis during a lead-in period prior to receiving the gene therapy.
The overall median annualized bleeding rate was zero after treatment with Beqvez, compared with 1.3 bleeds per year during the lead-in period. The mean annualized bleeding rate dropped from 4.5 bleeds per year while patients were on prophylaxis to 2.5 bleeds per year after receiving Beqvez.
An ultimate goal of gene therapy would be for patients to be less reliant on replacement therapy, or to eliminate it altogether, avoiding years of medical burden, Bhatia said.
Still, the long-term effects of Beqvez, and whether it will offer sustained bleed control for many years, will only be known once treated patients have been followed for a longer period of time.
BENEGENE-2 participants are being followed for up to 15 years: six years in the current study and nine more in a long-term Phase 3 extension study (NCT05568719).
Bhatia said Pfizer is optimistic about the gene therapys long-term safety and efficacy profile.
Patients from an earlier Phase 1/2a trial (NCT02484092) and long-term extension study (NCT03307980) have been followed for up to six years, during which time FIX activity has remained stable, according to Bhatia. With FIX activity generally in the mild hemophilia to normal range, patients have also maintained low bleed rates during that time.
While more long-term data are collected, the company is conducting exploratory modeling analyses aiming to predict the treatments long-term effects based on available clinical trial data.
Results from those analyses presented earlier this year indicated that a one-time infusion was predicted to be efficacious for more than 20 years, maintaining FIX at levels not achievable with recommended replacement therapy dosing. Bhatia said Pfizer will continue to update the modeling analyses as more data become available, adding that the current results are encouraging.
Bhatia touted the recent Beqvez approval as a testament to Pfizers continued effort to advance the standard of care for people living with hemophilia.
The company, which markets a number of approved hemophilia treatments, has other experimental ones in the pipeline. Those include giroctocogene fitelparvovec, a gene therapy for hemophilia A thats in Phase 3 testing, and marstacimab, an injectable therapy currently under review in the U.S. and Europe for hemophilia A and B patients without inhibitors.
Follow this link:
Hemophilia B gene therapy Beqvez offers new choice: Pfizer official - Hemophilia News Today
- Faulty Circuits (preview) [Last Updated On: April 7th, 2010] [Originally Added On: April 7th, 2010]
- Faulty Circuits (preview) [Last Updated On: April 7th, 2010] [Originally Added On: April 7th, 2010]
- Rare flowers and common herbal supplements get unmasked with plant DNA barcoding [Last Updated On: April 20th, 2010] [Originally Added On: April 20th, 2010]
- Rare flowers and common herbal supplements get unmasked with plant DNA barcoding [Last Updated On: April 20th, 2010] [Originally Added On: April 20th, 2010]
- Biomarker Studies Could Realize Goal of More Effective and Personalized Cancer Medicine [Last Updated On: April 27th, 2010] [Originally Added On: April 27th, 2010]
- Biomarker Studies Could Realize Goal of More Effective and Personalized Cancer Medicine [Last Updated On: April 27th, 2010] [Originally Added On: April 27th, 2010]
- Schizophrenia shares genetic links with autism, genome study shows [Last Updated On: May 12th, 2010] [Originally Added On: May 12th, 2010]
- Schizophrenia shares genetic links with autism, genome study shows [Last Updated On: May 12th, 2010] [Originally Added On: May 12th, 2010]
- Alzheimer's: Forestalling the Darkness with New Approaches (preview) [Last Updated On: May 28th, 2010] [Originally Added On: May 28th, 2010]
- Alzheimer's: Forestalling the Darkness with New Approaches (preview) [Last Updated On: May 28th, 2010] [Originally Added On: May 28th, 2010]
- Large-Scale Autism Study Reveals Disorder's Genetic Complexity [Last Updated On: June 12th, 2010] [Originally Added On: June 12th, 2010]
- Large-Scale Autism Study Reveals Disorder's Genetic Complexity [Last Updated On: June 12th, 2010] [Originally Added On: June 12th, 2010]
- Cancer Therapy Goes Viral: Progress Is Made Tackling Tumors with Viruses [Last Updated On: June 24th, 2010] [Originally Added On: June 24th, 2010]
- Cancer Therapy Goes Viral: Progress Is Made Tackling Tumors with Viruses [Last Updated On: June 24th, 2010] [Originally Added On: June 24th, 2010]
- Vaccines Derived from Patients' Tumor Cells Are Individualizing Cancer Treatment [Last Updated On: June 26th, 2010] [Originally Added On: June 26th, 2010]
- Vaccines Derived from Patients' Tumor Cells Are Individualizing Cancer Treatment [Last Updated On: June 26th, 2010] [Originally Added On: June 26th, 2010]
- A genome story: 10th anniversary commentary by Francis Collins [Last Updated On: June 29th, 2010] [Originally Added On: June 29th, 2010]
- A genome story: 10th anniversary commentary by Francis Collins [Last Updated On: June 29th, 2010] [Originally Added On: June 29th, 2010]
- Hair Trigger: How a Cell's Primary Cilium Functions as a Molecular Antenna [Last Updated On: June 30th, 2010] [Originally Added On: June 30th, 2010]
- Hair Trigger: How a Cell's Primary Cilium Functions as a Molecular Antenna [Last Updated On: June 30th, 2010] [Originally Added On: June 30th, 2010]
- DNA Drugs Come of Age (preview) [Last Updated On: July 16th, 2010] [Originally Added On: July 16th, 2010]
- DNA Drugs Come of Age (preview) [Last Updated On: July 16th, 2010] [Originally Added On: July 16th, 2010]
- 2 Genes Linked to Embryonic Brain Impairment in Down's Syndrome [Last Updated On: July 22nd, 2010] [Originally Added On: July 22nd, 2010]
- 2 Genes Linked to Embryonic Brain Impairment in Down's Syndrome [Last Updated On: July 22nd, 2010] [Originally Added On: July 22nd, 2010]
- Stem Cells from Reprogrammed Adult Cells Found to Bring Along Genetic Defects of Their Donors [Last Updated On: October 11th, 2010] [Originally Added On: October 11th, 2010]
- Was Darwin a Punk? A Q&A with Punker-Paleontologist Greg Graffin [Last Updated On: October 11th, 2010] [Originally Added On: October 11th, 2010]
- Parkinsonian Power Failure: Neuron Degeneration May Be Caused by a Cellular Energy System Breakdown [Last Updated On: October 11th, 2010] [Originally Added On: October 11th, 2010]
- Was Darwin a Punk? A Q&A with Punker-Paleontologist Greg Graffin [Last Updated On: October 11th, 2010] [Originally Added On: October 11th, 2010]
- Desperation Drives Parents to Dubious Autism Treatments (preview) [Last Updated On: October 13th, 2010] [Originally Added On: October 13th, 2010]
- Revolution Postponed: Why the Human Genome Project Has Been Disappointing (preview) [Last Updated On: October 26th, 2010] [Originally Added On: October 26th, 2010]
- Controlling the Brain with Light (preview) [Last Updated On: October 26th, 2010] [Originally Added On: October 26th, 2010]
- Optogenetics: Controlling the Brain with Light [Extended Version] [Last Updated On: October 26th, 2010] [Originally Added On: October 26th, 2010]
- Clear New Insights into the Genetics of Depression [Last Updated On: November 7th, 2010] [Originally Added On: November 7th, 2010]
- TEDMED 2010: Technology and the people [Last Updated On: November 7th, 2010] [Originally Added On: November 7th, 2010]
- Bacteria, the anti-cancer soldier [Last Updated On: November 7th, 2010] [Originally Added On: November 7th, 2010]
- Clear New Insights into the Genetics of Depression [Last Updated On: November 7th, 2010] [Originally Added On: November 7th, 2010]
- TEDMED 2010: Technology and the people [Last Updated On: November 7th, 2010] [Originally Added On: November 7th, 2010]
- Bacteria, the anti-cancer soldier [Last Updated On: November 7th, 2010] [Originally Added On: November 7th, 2010]
- Scientific regress: When science goes backward [Last Updated On: November 29th, 2010] [Originally Added On: November 29th, 2010]
- Can You Live Forever? Maybe Not--But You Can Have Fun Trying [Last Updated On: December 26th, 2010] [Originally Added On: December 26th, 2010]
- How to Fix the Obesity Crisis (preview) [Last Updated On: February 14th, 2011] [Originally Added On: February 14th, 2011]
- Personalizing cancer medicine [Last Updated On: February 14th, 2011] [Originally Added On: February 14th, 2011]
- New Salmonella strain delivers gene-based therapy to fight virus in mice [Last Updated On: February 14th, 2011] [Originally Added On: February 14th, 2011]
- How to Fix the Obesity Crisis (preview) [Last Updated On: February 14th, 2011] [Originally Added On: February 14th, 2011]
- Personalizing cancer medicine [Last Updated On: February 14th, 2011] [Originally Added On: February 14th, 2011]
- New Salmonella strain delivers gene-based therapy to fight virus in mice [Last Updated On: February 14th, 2011] [Originally Added On: February 14th, 2011]
- Steps toward a Bionic Eye [Last Updated On: February 20th, 2011] [Originally Added On: February 20th, 2011]
- Steps toward a Bionic Eye [Last Updated On: February 20th, 2011] [Originally Added On: February 20th, 2011]
- Giving HIV a Poor Reception: New AIDS Treatment Tinkers with Immune Cell Genes [Last Updated On: March 6th, 2011] [Originally Added On: March 6th, 2011]
- Giving HIV a Poor Reception: New AIDS Treatment Tinkers with Immune Cell Genes [Last Updated On: March 6th, 2011] [Originally Added On: March 6th, 2011]
- Smaller, cheaper, faster: Does Moore's law apply to solar cells? [Last Updated On: March 27th, 2011] [Originally Added On: March 27th, 2011]
- Smaller, cheaper, faster: Does Moore's law apply to solar cells? [Last Updated On: March 27th, 2011] [Originally Added On: March 27th, 2011]
- New Drugs for Hepatitis C on the Horizon [Last Updated On: April 10th, 2011] [Originally Added On: April 10th, 2011]
- Can we capture all of the world's carbon emissions? [Last Updated On: April 10th, 2011] [Originally Added On: April 10th, 2011]
- New Drugs for Hepatitis C on the Horizon [Last Updated On: April 10th, 2011] [Originally Added On: April 10th, 2011]
- Can we capture all of the world's carbon emissions? [Last Updated On: April 10th, 2011] [Originally Added On: April 10th, 2011]
- Drug-resistant genes found in cholera and dysentery strains in New Delhi water supply [Last Updated On: May 1st, 2011] [Originally Added On: May 1st, 2011]
- Fast Track to Vaccines: How Systems Biology Speeds Drug Development (preview) [Last Updated On: May 1st, 2011] [Originally Added On: May 1st, 2011]
- Drug-resistant genes found in cholera and dysentery strains in New Delhi water supply [Last Updated On: May 1st, 2011] [Originally Added On: May 1st, 2011]
- Fast Track to Vaccines: How Systems Biology Speeds Drug Development (preview) [Last Updated On: May 1st, 2011] [Originally Added On: May 1st, 2011]
- Autism's Tangled Genetics Full of Rare and Varied Mutations [Last Updated On: June 19th, 2011] [Originally Added On: June 19th, 2011]
- A New Look at Obsessive-Compulsive Disorder (preview) [Last Updated On: June 19th, 2011] [Originally Added On: June 19th, 2011]
- Autism's Tangled Genetics Full of Rare and Varied Mutations [Last Updated On: June 19th, 2011] [Originally Added On: June 19th, 2011]
- A New Look at Obsessive-Compulsive Disorder (preview) [Last Updated On: June 19th, 2011] [Originally Added On: June 19th, 2011]
- Close Encounters of Science and Medicine [Last Updated On: July 3rd, 2011] [Originally Added On: July 3rd, 2011]
- Close Encounters of Science and Medicine [Last Updated On: July 3rd, 2011] [Originally Added On: July 3rd, 2011]
- New Report Details Uphill Battle to Solve the U.S.'s Pain Problem [Last Updated On: July 24th, 2011] [Originally Added On: July 24th, 2011]
- New Report Details Uphill Battle to Solve the U.S.'s Pain Problem [Last Updated On: July 24th, 2011] [Originally Added On: July 24th, 2011]
- A Breath of Fresh Air: New Hope for Cystic Fibrosis Treatment (preview) [Last Updated On: August 7th, 2011] [Originally Added On: August 7th, 2011]
- A Breath of Fresh Air: New Hope for Cystic Fibrosis Treatment (preview) [Last Updated On: August 7th, 2011] [Originally Added On: August 7th, 2011]
- Sickle Cell Anemia: Stem Cell Gene Therapy - Donald Kohn [Last Updated On: August 18th, 2011] [Originally Added On: August 18th, 2011]
- Sickle Cell Anemia: Stem Cell Gene Therapy - A Patient's Perspective [Last Updated On: October 8th, 2011] [Originally Added On: October 8th, 2011]
- Gene therapy improves stem cell transplantation - Video [Last Updated On: October 14th, 2011] [Originally Added On: October 14th, 2011]
- THE NEW MORGELLONS HAIR - Video [Last Updated On: October 14th, 2011] [Originally Added On: October 14th, 2011]
- Studying Mental Illness in a Dish [Last Updated On: November 13th, 2011] [Originally Added On: November 13th, 2011]
- The Puzzle of Pancreatic Cancer: How Steve Jobs Did Not Beat the Oddsbut Nobel Winner Ralph Steinman Did [Last Updated On: November 13th, 2011] [Originally Added On: November 13th, 2011]
- Did Alternative Medicine Extend or Abbreviate Steve Jobs's Life? [Last Updated On: November 13th, 2011] [Originally Added On: November 13th, 2011]
- Calendar: MIND Events in November and December [Last Updated On: November 13th, 2011] [Originally Added On: November 13th, 2011]
- Studying Mental Illness in a Dish [Last Updated On: November 13th, 2011] [Originally Added On: November 13th, 2011]
- The Puzzle of Pancreatic Cancer: How Steve Jobs Did Not Beat the Odds?but Nobel Winner Ralph Steinman Did [Last Updated On: November 13th, 2011] [Originally Added On: November 13th, 2011]